2m 2m 2m 2m 2m 2m 2m
VERA THERAPEUT-A (VERA)
NASDAQ
$29.47-$1.73 (-5.53%)
Price as of Oct 22, 2026 7:41 PM EDT- $2.2BMarket Cap
- 4.21%1-Year Change
- BiotechnologyIndustry
VERA THERAPEUT-A (VERA)
$29.47-$1.73 (-5.53%)
VERA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.20 | ||
Change | +$1.14 (+3.79%) | ||
Open | $30.01 | ||
High | $31.57 | ||
Low | $29.85 | ||
Previous Close | $30.06 | ||
Volume | 2,083,728 | ||
30-Day Average Volume | 1,736,870 | ||
1-Week Change | 16.68% | ||
1-Month Change | -8.91% | ||
1-Year Change | 4.21% | ||
3-Year Change | 217.07% | ||
5-Year Change | 88.52% | ||
Fundamentals | |||
Shares Outstanding | 72.1M | ||
Total Assets | $533.0M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | -$247,000.00 | ||
Net Income | -$109.5M | ||
Free Cash Flow | -$100.3M | ||
EBIT | -$109.5M | ||
EBITDA | -$109.3M | ||
Net Working Capital | $479.2M | ||
EPS | -$1.52 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | -9,209 | ||
P/B | 6 | ||
P/E | -21 | ||
PEG | -2 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue